Background: Elevated serum immunoglobulin (Ig) E is a diagnostic marker of immediate-type allergic reactions. We hypothesize that serum IgE does not necessarily reflect total body IgE because in vivo IgE can be bound to cell surface receptors such as FceRI and FceRII (CD23). The aim of this study was to analyze the relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells in a pediatric population.
Introduction
Immunoglobulin (Ig) E and its cell surface receptors, the high affinity receptor FceRI and the low affinity receptor FceRII (CD23), are key components of immediate-type allergic reactions [1] . IgE activates the allergic cascade effectively via the high affinity receptor, FceRI, on blood-and tissue cells. As a member of the immunoglobulin receptor superfamily, FceRI consists of a ligand-binding immunoglobulin domain-containing protein (achain) which binds the Fc-part of IgE and signaling subunits that regulate cellular activation (b-and c-chains) [2] . Humans express a tetrameric FceRI (FceRIabc 2 ) on mast cells and basophils and a trimeric form (FceRIac 2 ) on antigen presenting cells [2, 3] . FceRI expression is regulated by IgE since binding of monomeric IgE to FceRIa stabilizes the receptor at the cell surface as an IgE-FceRI complex [4, 5, 6] . Hence, in vivo, individuals with high serum IgE levels show enhanced FceRI surface expression on peripheral blood basophils, monocytes, and dendritic cells [7, 8, 9 ].
In the blood, the low affinity IgE receptor CD23 is expressed on B-cells [1] , monocytes [10] , and dendritic cells [11, 12] . CD23 is a member of the C-type lectin superfamily. Its IgE binding sites consist of 3 lectin-type head domains on triple a-helical coiled-coil stalk domains [1] . The stalk region of CD23 is sensitive to proteolysis, which results in the release of soluble fragments [13, 14] . No correlation between serum IgE and cell surface CD23 levels has been described [10] . In fact, CD23 is being discussed as a regulator of IgE synthesis through a complex interplay of coligations of CD23, soluble CD23, IgE, IgE-allergen complexes, and the complement receptor CD21 on B-cells [1] .
Serum IgE is an essential laboratory parameter in the diagnosis of allergies. Serum IgE levels generally correlate with the severity of allergic diseases [15, 16, 17] . However, a subgroup of allergic patients has serum IgE levels in the normal range [18, 19] . We therefore hypothesized that serum IgE does not necessarily reflect total body IgE because in vivo IgE can be bound to its cell surface receptors FceRI and CD23. The aim of this study was to analyze the relationships between levels of serum IgE, cell-bound IgE, and IgE-receptors on peripheral blood cells of pediatric patients.
Materials and Methods

Study population
This analysis was performed as a substudy within an ongoing prospective cohort study on the role of FceRI in the gastrointestinal tract. Patients scheduled for an elective esophago-gastro-duodenoscopy at the Division of Gastroenterology at Children's Hospital Boston were randomly invited to participate. Subjects between 1 and 18 years of age were enrolled. Patients' characteristics such as age, gender, and race were obtained in a structured interview. Subjects with a recent (,3 months) use of steroid in any form, immunomodulatory drugs, mast cell stabilizer, or leukotriene inhibitor, as well as patients with an established diagnosis of autoimmune, inflammatory, or immunodeficiency disease and patients under 1 year of age were excluded from the study. The study protocol was approved by the Investigational Review Board at Children's Hospital Boston (Harvard Medical School, Boston, MA). Patients or their legal guardians provided written informed consent. We obtained peripheral blood samples for serum IgE measurements and flow cytometry analysis at the time of enrollment.
Total serum IgE
Total serum IgE was determined using a solid-phase ELISA (DiaMed Eurogen, Turnhout, Belgium) according to the manufacturer's instructions. In brief, plates pre-coated with an anti-IgE monoclonal antibody were incubated with patient sera and a second anti-IgE antibody conjugated to horseradish peroxidase. After washing, levels of bound IgE were determined by incubating with tetramethylbenzidine (TMB) solution and stopping the reaction with 2N H 2 SO 4 before reading ODs at 450 nm. Normal serum IgE levels are given by the manufacturer as ,10 IU/ml for age 0-3 years, ,25 IU/ml for 3-4 years, ,50 IU/ml for 4-7 years, ,100 IU/ml for 7-14 years, and ,150 IU/mL for adults older than age 14. IgE levels above the age specific normal range are referred to as 'elevated' IgE from here on.
Flow cytometry analysis of IgE-receptors and IgE on peripheral blood cells 100 microl of K2EDTA blood were stained following the Becton Dickinson protocol for direct immunofluorescence staining of whole blood (http://www.bdbiosciences.ca/canada/downloads/ is_protocols/IF_WB_LW.pdf). The following antibodies were used: anti-IgE FITC (Invitrogen), anti-FceRIa APC (mAb CRA1, eBioscience, San Diego, CA), anti-CD23 APC, anti-myeloperoxidase (MPO)-PE for neutrophils, anti-CD14 PerCP-Cy5.5 for monocytes, anti-CD11c V450 and anti-MHC class II-PerCP (all BD Biosciences) for dendritic cells. Basophils were identified by anti-CD123-PE (BD) and negativity for MHC class II.
Blood was incubated with antibodies for 20 minutes at room temperature to stain for cell surface IgE, IgE receptors and linagespecific surface markers. Red blood cells were lysed with 16 BD FACS TM Lysing Solution (BD Biosciences, San Jose, CA). After surface staining, neutrophils were identified by intracellular expression of MPO using FIX&PERMH (Invitrogen, Carlsbad, CA) according to the manufacturer's guidelines. Cells were washed and resuspended in PBS for flow cytometry analysis. Corresponding isotype controls were performed for each staining.
Data were acquired with a DakoCytomation MoFlo Legacy (Dako North America Inc., Capinteria, CA) and analyzed with Summit for Windows Version 4.3 (Dako North America Inc.). Typically, 20,000 events within the granulocytes/monocytes gate in the forward/side scatter plot were acquired. FceRI and CD23 levels were determined as percent (%) positive cells among cell type after subtraction of the individual isotype control background. Cell-bound IgE levels were recorded as the percentage of cells that were double positive for IgE and FceR1 or IgE and CD23 after subtraction of background.
Statistical analysis
Data were analysed with SPSS for Windows (version 16.0, SPSS Inc., Chicago, IL). Chi-square test was used for nominal variables. Continuous variables were compared by Student's T-test or MannWhitney-U where called for. Correlations were calculated using Spearman's rank correlation test since datasets were not normally distributed. Spearman's rank correlation coefficients are displayed as 'rho'. To account for age-dependent normal ranges, total IgE levels were converted into z-units as published by Kjellman et al. [20] . A p-value of ,0.05 was considered significant.
Results
A total of 48 pediatric patients were included in the study between October 3, 2008 and July 17, 2009 (26 boys, 22 girls, mean age 10.365.4years). The characteristics of the study population are given in Table 1 .
Surface FceRI on peripheral blood dendritic cells and monocytes correlates with serum IgE levels in children with elevated IgE
All patients expressed FceRI on their dendritic cells (DCs). FceRI-expression ranged between 2.54 and 26.43% FceRI+ DCs ( Table 2 Patients with elevated serum IgE (n = 14) showed a significant correlation between age-normalized serum IgE z-units and FceRI on dendritic cells (rho = 0.552, p = 0.041, Figure 2A) . A tendency towards correlation between expression and z-units on monocytes was observed (rho = 0.514, p = 0.06, Figure 2A ). FceRI on basophils and neutrophils showed no association with serum IgE (Figure 2A ), nor did FceRI expression levels in children with normal IgE (n = 34, Figure 2B ). Numbers of CD23+ cells were lower than FceRI+ cells (Table 2 ). DCs from 20 and monocytes from 11 out of 48 patients expressed this receptor (0.03%-4.25% CD23+ DCs and 0.29-6.96% CD23+ monocytes in individual subjects). One patient expressed CD23 on basophils and another one on neutrophils. Surface CD23-levels did not correlate with serum IgE (IU/l or z-units) on any of the cell types analyzed in this study (data not shown). On FceRI+ DCs, monocytes, and neutrophils, a positive correlation between cell-bound IgE and absolute total serum IgE was detected (IU/l, Table 3A ). Accordingly, age-normalized IgE levels in z-units correlated positively with IgE on the surface of FceRI+ DCs and monocytes (rho = 0.415, p = 0.003 and rho = 0.354, p = 0.013, respectively, Table 3A ). Cell-bound IgE on CD23+ cells did not correlate with serum IgE.
Cell surface-bound
Cell-bound IgE was linked to IgE-receptor expression. FceRIexpression significantly correlated with cell-bound IgE in FceRI+ DC's, monocytes, and basophils. CD23-expression correlated with cell-surface IgE in CD23+ DC and monocytes (Table 3B ).
IgE-positive peripheral blood cells are detected in the absence of elevated serum IgE levels
We next analyzed whether elevated serum IgE is reflected by high numbers of cell-bound IgE. We found that numbers of IgEpositive cells did not significantly differ between children with elevated and normal serum IgE (Mann-Whitney-U test, Figure 3 ). We found, however, a considerable number of patients with high levels of cell-bound IgE on their monocytes, basophils, and neutrophils despite normal serum IgE. These data provide evidence that the body IgE-pool consists of a soluble serum IgE fraction and a circulating cell-bound fraction.
Discussion
In this work we have correlated levels of cell-bound IgE on peripheral blood cells of pediatric patients with total serum IgE and IgE-receptors. Analyzing expression of the high affinity IgE receptor FceRI, we observed a slight increase of FceRI expression on DC and monocytes with age, which is in line with previous findings by Wada et al. [21] . We found that the majority of FceRI+ dendritic cells, monocytes, basophils and neutrophils carry IgE on their surface. Serum IgE levels correlated positively with levels of cell-bound IgE. Serum IgE positively correlated with FceRI levels on dendritic cells and to a lesser extent on monocytes in children with elevated IgE. We also found a population of patients that carry high amounts of cell-bound IgE in the absence of elevated levels of serum IgE.
An association between cell surface density of FceRI and serum IgE levels has been described for adult atopic patients [7, 8, 9, 22, 23] . In mixed-age pediatric populations, comparing IgE values is complicated by age-related normal ranges for IgE and such a relation has not been described yet. In healthy children, the normal range for serum IgE increases with age, hence absolute IgE levels have a different pathophysiological relevance in different age groups. Comparing absolute values would not account for these age-dependent cut-off levels. This problem is commonly solved by converting absolute IgE levels to age-normalized z-values as published by Kjellman et al. [20] . Using age-related z-units, we here demonstrated that high levels of serum IgE are associated with high surface expression of FceRI in children as well. Another novel finding of this study is the close positive correlation between cell-bound IgE and FceRI on DC, monocytes, and basophils in children. Our findings support previous data showing that serum IgE is associated with an upregulation of FceRI as a consequence of IgE binding and stabilization of the receptor complex on the cell surface [4, 5, 6] . In line with previous reports, we showed that FceRI on neutrophils in our study population was neither regulated by serum-nor cell-bound IgE. This adds to the notion that IgE does not affect FceRI expression on neutrophils [24, 25] . CD23 expression was not associated with serum IgE, which is consistent with a previous report [10] . Hence, serum IgE does not seem to be involved in regulation of CD23 expression. CD23 expression was, however, correlated with cell-bound IgE. Receptor stabilization by IgE has not been described for CD23 yet. It has however been described that IgE-bound CD23 is shedded from the cell surface and that a soluble form of CD23 is found in patients with high levels of serum IgE [1] . As flow cytometry only allows for the identification of IgE and IgE-receptor doublepositive cells, we cannot assess if a receptor is in fact loaded with IgE. We thus cannot rule out that CD23+ cells actually bind IgE via FceRI. To our knowledge, it has also not been studied whether FceRI and CD23 expression are interrelated. One could speculate that IgE-mediated surface stabilization of FceRI synergistically regulates CD23 expression to maximize sensitivity towards IgE and IgE-allergen complexes.
In our study, cell-bound IgE on FceRI+ cells generally correlated well with elevated serum IgE. In a subgroup of patients though, monocytes, basophils, and neutrophils were loaded with IgE despite normal or low serum IgE levels. Allergic diseases in the absence of elevated serum IgE levels have been described in the literature [18, 19] . We conclude from our data that free serum IgE does not necessarily reflect the body IgE pool. In support of this idea, Liang et al. recently showed IgE-positive cells in peripheral blood. As in our pediatric population, Liang et al. found in healthy and allergic adults that, cell surface-bound IgE and serum IgE correlate well. In line with our findings, this study also observed a discordance in serum IgE and cell-bound IgE in some individuals [26] . We thus propose that the body IgE-pool is composed of a soluble serum IgE fraction and a circulating cell-bound fraction. IgE bound to the high affinity IgE-receptor, FceRI, on immune effector cells can travel to sites of allergen contact like mucous membranes and cause allergic symptoms. In patients with normal serum IgE as defined by conventional IgE-assays, cell surface bound IgE could sensitize immune cells and trigger allergic reactions. Unfortunately, no data on physician-diagnosed allergies was available for our study population. Due to this limitation of our study, we can only speculate about the role of cell-bound IgE in allergic conditions at this point. Further prospective studies are currently being performed to address this important topic.
Comparable to the increase in FceRI expression by elevated serum IgE, monoclonal anti-IgE antibodies, such as Omalizumab, decrease serum IgE and FceRI-surface expression on dendritic cells, monocytes, and basophils [27, 28, 29, 30] . Lower levels of surface FceRI consequently render immune cells less sensitive to allergen stimuli [31] . Determining cell-bound IgE could be a valuable additional parameter in monitoring IgE-sensitized immune cells during anti-IgE therapy. Overall, measuring cellbound IgE could be particularly useful in estimating the allergy risk of children with normal serum IgE levels.
In summary, we find that in pediatric patients, levels of ageadjusted serum IgE and IgE-receptors correlate. The majority of FceRI+ cells also carry IgE on their surface. Cell-bound IgE on FceRI+ cells correlated well with high levels of serum IgE. We also identified pediatric patients who carried IgE at the surface of peripheral blood cells while serum IgE levels were normal. Further prospective cohort studies are needed for a detailed analysis of the correlation between cell-bound IgE with clinical symptoms of allergy and therapeutic responses. We propose here that measuring cell-bound IgE could be a valuable additional laboratory parameter in the assessment of IgE-mediated allergies. 
